Gulf International Bank UK Ltd Has $5.68 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Gulf International Bank UK Ltd grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,033 shares of the company’s stock after acquiring an additional 95 shares during the quarter. Gulf International Bank UK Ltd’s holdings in HCA Healthcare were worth $5,681,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of HCA. Stone House Investment Management LLC bought a new position in HCA Healthcare during the 3rd quarter worth $25,000. Centerpoint Advisors LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $27,000. Atlantic Edge Private Wealth Management LLC bought a new stake in HCA Healthcare during the fourth quarter worth $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $28,000. Finally, Rise Advisors LLC acquired a new position in HCA Healthcare during the first quarter worth about $36,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.2 %

NYSE HCA opened at $338.92 on Friday. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. The business has a fifty day simple moving average of $322.65 and a 200 day simple moving average of $315.58. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $343.53. The firm has a market capitalization of $88.77 billion, a P/E ratio of 16.90, a PEG ratio of 1.57 and a beta of 1.69.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.01 by $0.35. The company had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s quarterly revenue was up 11.2% on a year-over-year basis. During the same period in the prior year, the company posted $4.93 earnings per share. On average, analysts predict that HCA Healthcare, Inc. will post 20.92 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.78%. HCA Healthcare’s payout ratio is 13.16%.

Insider Activity

In related news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the sale, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jeffrey E. Cohen sold 1,650 shares of HCA Healthcare stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the transaction, the senior vice president now owns 5,185 shares of the company’s stock, valued at approximately $1,622,905. The disclosure for this sale can be found here. Over the last three months, insiders have sold 12,397 shares of company stock valued at $3,921,929. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HCA. TD Cowen cut their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Barclays boosted their price target on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Wells Fargo & Company increased their price objective on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Finally, Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target for the company. Four investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $325.59.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.